tirzepatide and type 2 diabetes once weekly for the treatment of obesity in people with (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Type 2 diabetes: Adding Mounjaro

Circadian rhythms in glutathione and glutathione-S transferase activity of rat liver [PMID: 1380339] Laboratory literature summary: Circadian rhythms in glutathione and glutathione-S transferase activity of rat liver

When administered the peptide, mice with moderate AD exhibited a reduced level of amyloid beta plaques in the brain, improved cognitive functionality and synaptic transmission, and protection against neuronal death

They are not for human consumption, veterinary use, diagnostic procedures, cosmetic use, therapeutic applications, or medical treatment

The study, a phase 2 multicenter, dose-ranging trial including 71 clinical sites across eight nations, was conducted